Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Effect of fenofibrate on brachial artery flow-mediated dilatation in type 2 diabetes mellitus.

× No keyword cloud information.

20 in total

Review 1. Mechanisms, significance and treatment of vascular dysfunction in type 2 diabetes mellitus: focus on lipid-regulating therapy.

Authors: Richard J Woodman; Gerard T Chew; Gerald F Watts
Journal: Drugs Date: 2005 Impact factor: 9.546

Review 2. Fenofibrate: a review of its use in primary dyslipidaemia, the metabolic syndrome and type 2 diabetes mellitus.

Authors: Gillian M Keating; Katherine F Croom
Journal: Drugs Date: 2007 Impact factor: 9.546

Review 3. Cardiometabolic impact of non-statin lipid lowering therapies.

Authors: Parag Goyal; Leon I Igel; Keith LaScalea; William B Borden
Journal: Curr Atheroscler Rep Date: 2014-02 Impact factor: 5.113

Review 4. Fenofibrate: a review of its use in dyslipidaemia.

Authors: Kate McKeage; Gillian M Keating
Journal: Drugs Date: 2011-10-01 Impact factor: 9.546

Review 5. Endothelial dysfunction in diabetes: pathogenesis, significance, and treatment.

Authors: Sandra J Hamilton; Gerald F Watts
Journal: Rev Diabet Stud Date: 2013-08-10

Review 6. PPARalpha: an emerging therapeutic target in diabetic microvascular damage.

Authors: Anne Hiukka; Marianna Maranghi; Niina Matikainen; Marja-Riitta Taskinen
Journal: Nat Rev Endocrinol Date: 2010-06-22 Impact factor: 43.330

Review 7. The role of hypertriglyceridemia in atherosclerosis.

Authors: Ngoc-Anh Le; Mary F Walter
Journal: Curr Atheroscler Rep Date: 2007-08 Impact factor: 5.113

8. Inhibitory effects of fenofibrate on apoptosis and cell proliferation in human endothelial cells in high glucose.

Authors: Michela Zanetti; Alessia Stocca; Barbara Dapas; Rossella Farra; Laura Uxa; Alessandra Bosutti; Rocco Barazzoni; Fleur Bossi; Carlo Giansante; Francesco Tedesco; Luigi Cattin; Gianfranco Guarnieri; Gabriele Grassi
Journal: J Mol Med (Berl) Date: 2007-09-18 Impact factor: 4.599

Review 9. Role of fibric acid derivatives in the management of risk factors for coronary heart disease.

Authors: Jean-Pierre Després; Isabelle Lemieux; Sander J Robins
Journal: Drugs Date: 2004 Impact factor: 9.546

Review 10. Atherosclerosis and cardiovascular risk reduction with PPAR agonists.

Authors: Johanna Kuusisto; Laura Andrulionyte; Markku Laakso
Journal: Curr Atheroscler Rep Date: 2007-10 Impact factor: 5.113